Results 161 to 170 of about 27,341 (230)

Novel ABCG8 Mutation in Pediatric Sitosterolemia: A Case Report of Siblings with Hemolytic Anemia. [PDF]

Hematol Transfus Cell Ther
Saha S, Dolai TK, Ghosh K, Jajodia E.
europepmc   +1 more source

Ergosterol as a natural modulator of intestinal cholesterol absorption via NPC1L1: an <i>in silico</i> insight into hypercholesterolemia. [PDF]

Front Bioinform
Shenoy AG, Sureshkumar A, Ravi V, Raju R, Rehman N.   +4 more
europepmc   +1 more source

Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background. [PDF]

J Lipid Res
Inia JA, Zhang LH, Keijzer N, Worms N, van Nieuwkoop-van Straalen A, Ditmarsch M, de Kleer M, Jukema JW, Kastelein JJP, Szarek M, van den Hoek AM, Stokman G, Pieterman EJ, Princen HMG.   +13 more
europepmc   +1 more source

Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe

Drug Design, Development and Therapy
Hyungmi An,1 Dongseong Shin2 1Department of Statistics and Data Science, Korea National Open University, Seoul, Korea; 2Department of Clinical Pharmacology and Therapeutics, Gil Medical Center, Gachon University College of Medicine, Incheon ...
An H, Shin D
doaj  

Lipid lowering in coronary artery disease - not just statins. [PDF]

Clin Med (Lond)
Han J, Masmanian E, Wang T, Chua TP.
europepmc   +1 more source

Potential of oral combination lipid‑lowering therapy beyond statins: a simulation‑based perspective from the SANTORINI study. [PDF]

Am J Prev Cardiol
Santos RD.
europepmc   +1 more source

Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk. [PDF]

Trials
Nyein PP, Haskelberg H, Martinello M, Lowe M, Goodman-Meza D, Avihingsanon A, Kelleher AD, Rodgers A, Schutte AE, Nnakelu EC, Byakwaga H, Trevillyan J, Losso M, Kumarasamy N, Azwa RISR, Kaplan R, Clifton B, Arnott C, Dharan NJ, Petoumenos K, Matthews GV.   +20 more
europepmc   +1 more source

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes Vytorin Efficacy International Trial)

Circulation, 2018
R. Giugliano, C. Cannon, M. Blazing, J. Nicolau, R. Corbalán, J. Špinar, Jeong-Gun Park, Jennifer A. White, E. Bohula, E. Braunwald   +9 more
semanticscholar   +1 more source

Hyperuricemia risk in bempedoic acid-treated hyperlipidemic patients. [PDF]

Commun Med (Lond)
Su PH, Tsai DH, Hsieh MH, Vairaperumal T, Lai EC, Liu PY.   +5 more
europepmc   +1 more source

Moderate-intensity statin plus ezetimibe as an alternative to high-intensity statin therapy. [PDF]

Cardiovasc Diabetol
Albawa'neh AS, Ali BR.
europepmc   +1 more source